The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EBMT 2026 | EBMT guidelines for diagnosing and managing neurologic complications after alloSCT and CAR-T
In this video, Roser Velasco, MD, PhD, Catalan Institute of Oncology, Barcelona, Spain, provides insight into the upcoming EBMT guidelines for diagnosing and managing neurologic complications following allogeneic stem cell transplantation (alloSCT) and CAR T-cell therapy. Dr Velasco highlights that these guidelines will serve as a valuable tool for clinicians in their daily practice, enabling them to better identify neurologic complications early. This interview took place at the 52nd Annual Meeting of the EBMT in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Transcript
There are three upcoming guidelines that will be published soon because we have worked on trying to help the clinicians to be more aware of these complications and also to help them to identify the symptoms. So we think that they will be a good tool for them for helping in their daily clinical practice. One of the guidelines is focused on neurologic complications, including CNS and neuromuscular complications...
There are three upcoming guidelines that will be published soon because we have worked on trying to help the clinicians to be more aware of these complications and also to help them to identify the symptoms. So we think that they will be a good tool for them for helping in their daily clinical practice. One of the guidelines is focused on neurologic complications, including CNS and neuromuscular complications. Another of the guidelines is a general overview of the neurological complications, also with particularities in the imaging characteristics that we can find in these patients, and also the specific population, the pediatric population. And also, we have done a guideline focused on the symptoms and presentation to help clinicians to better identify the neurologic complications early.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
Read more...
